What dose of kanna do trials and labels give?

What the trials gave
TrialDose and schedulePeopleLength
NellOnce daily: 8 mg, 25 mg or placebo237 healthy adults (12, 12 and 13)3 months
Chiu25 mg once daily, then a 3-week washout, then placebo, or the reverse121 healthy subjects3 weeks per phase, 3-week washout
TerburgOne 25 mg dose of Zembrin and, 5 to 9 days apart, placebo (crossover)316 healthy participantsSingle dose
Hoffman25-mg Sceletium tortuosum extract supplementation for 8 days, or placebo4Sixty recreationally trained adults (48 men, 12 women, aged 20 to 35)8 days
ReayOne 25 mg dose of Zembrin or placebo, in two between-subject studies520 young healthy volunteersSingle dose

Two placebo-controlled trials of the kanna extract Zembrin gave 25 mg once daily, for 3 weeks to 21 healthy subjects (Chiu) and, beside an 8 mg arm, for 3 months to 37 healthy adults (Nell); a DailyMed search returned no US label.12

What the trials gave

The table is set at the top of the page

In the Terburg study the dose was one capsule containing 25 mg of Zembrin, which the authors say is equivalent to 50 mg of dry raw plant material.3 In the Chiu crossover study the 25 mg capsule was taken orally once a day.1

Label, registry and regulator status

A DailyMed search for kanna and Sceletium returned no labels. The manufacturer PLT Health Solutions and a SupplySide report both say Health Canada's natural health product licence for Zembrin states that a 25 mg dose, taken for a minimum of 3 weeks, "helps support cognitive functioning in adults"; this is company-reported licence text, not the licence record.67 A South African trade association, SABPA, announced self-affirmed GRAS status in the United States for kanna raw material use; the announcement gives no dose, and a self-affirmation is the association's own determination, not an FDA decision.8 Registry entry NCT05471804 lists a 25 mg per day arm in a placebo-controlled trial lasting 8 weeks in healthy adults aged 30 to 50 with no results posted, and NCT07511088, still recruiting, lists 25 mg taken as needed once per day in a two-arm crossover study.910

How kanna is supplied and prepared

In the Terburg study each capsule held 25 mg of Zembrin extract, but DailyMed returned no label and none of the sources searched lists the strengths sold commercially.3 A review says kanna is traditionally mainly masticated or smoked.11 Mixing kanna powder with water or fermenting it, with quantities, is not described in the PubMed records and reviews searched.

Safety findings and open questions

In the Nell trial of 37 healthy adults, the authors report both Zembrin doses (8 mg and 25 mg) were well tolerated when used once daily for 3 months, with headache the most common adverse event, followed by abdominal pain and upper respiratory tract infections, all more frequent on placebo.2 A review of animal and clinical studies says not all studies showed consistent benefits and calls for large-scale clinical trials in relevant populations.12

Frequently asked questions

How should kanna be stored?

No storage conditions for kanna turned up in searches of DailyMed, PubMed and ClinicalTrials.gov.

How do you turn a kanna dose into a syringe mark?

The trial and registry capsules are taken by mouth, a review says kanna is traditionally mainly masticated or smoked, and none of the sources searched gives a concentration in mg per mL, so there is no syringe mark to work out.11011

References

  1. PubMed Central. Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia. 2014. pmc.ncbi.nlm.nih.gov
  2. PubMed. A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults. 2013. pubmed.ncbi.nlm.nih.gov
  3. PubMed Central. Acute Effects of Sceletium tortuosum (Zembrin), a Dual 5-HT Reuptake and PDE4 Inhibitor, in the Human Amygdala and its Connection to the Hypothalamus. 2013. pmc.ncbi.nlm.nih.gov
  4. PubMed. Ergogenic Effects of 8 Days of Sceletium Tortuosum Supplementation on Mood, Visual Tracking, and Reaction in Recreationally Trained Men and Women. 2020. pubmed.ncbi.nlm.nih.gov
  5. PubMed. Sceletium tortuosum (Zembrin® ) ameliorates experimentally induced anxiety in healthy volunteers. 2020. pubmed.ncbi.nlm.nih.gov
  6. PLT Health Solutions. PLT Health Solutions Receives License Confirming Health Claim for Zembrin® in Canada. plthealth.com
  7. SupplySide. PLT Health Solutions Receives License for Cognitive Health Ingredient. supplysidesj.com
  8. NutraIngredients. Across the Nutraverse: Sceletium self-GRAS, Buck Institute-Oracle partnership, eimele’s expansion plans. nutraingredients.com
  9. ClinicalTrials.gov. NCT05471804: Psychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract. 2022. clinicaltrials.gov
  10. ClinicalTrials.gov. NCT07511088: Decentralized Study to Evaluate a Dietary Supplement for Episodes of Mild Acute Stress in Healthy People. 2026. clinicaltrials.gov
  11. PubMed. Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological and clinical activities. 2021. pubmed.ncbi.nlm.nih.gov
  12. PubMed. Mesembryanthemum tortuosum and Zembrin: Mixed Evidence from In vivo Animal and Clinical Studies on their Antidepressant and Anxiolytic Effects. 2026. pubmed.ncbi.nlm.nih.gov